Board News and Announcements

 

RSS - XML Feed Add NCBOP RSS Feeds

 

 

APRIL 2014 NEWSLETTER

 

 

MONDAY, APRIL 14, 2014 - PLEASE VOTE FOR NORTHEASTERN AND CENTRAL DISTRICT BOARD CANDIDATES

Voting began on Monday, April 14, 2014 and will last through May 15, 2014. NC Pharmacists - Click here to log in and cast your vote now.

Two positions are up for election: The Northeastern District seat presently held by Gene Minton, and the Central District seat presently held by Lazelle Marks. 

Candidates are:

CENTRAL DISTRICT (Seat presently held by Lazelle Marks)
Brent Clevenger, Mecklenburg County
Stan Haywood, Randolph County
Kevin Isaacs, Union County
Max Gardner Reece, Jr, Montgomery County
Scott Romesburg, Union County
Marianne White, Chatham County

CLICK HERE FOR PHOTOS AND BIOS OF THE SIX CENTRAL DISTRICT CANDIDATES.

NORTHEASTERN DISTRICT (Seat presently held by Gene Minton)
David Catalano, Wake County
Thomas "Tom" D'Andrea, Wake County
Gene Minton, Halifax County
Christopher R. Peoples, Franklin County
Brooke Rawls, Wake County

CLICK HERE FOR PHOTOS AND BIOS OF THE FIVE NORTHEASTERN DISTRICT CANDIDATES.

Online voting will last through May 15, 2014. All pharmacists who live in North Carolina and who are actively licensed as of March 15, 2014 are eligible to vote.

Please contact Kristin Moore or Jay Campbell at the Board office if you have questions about the election process.

 


 

THURSDAY, APRIL 3, 2014

Appointment for Representative of the Rehabilitation Technology Suppliers to the DME Subcommittee.  Mel Elliott has resigned from the DME Subcommittee after years of distinguished service as the representative of the rehabilitation technology suppliers.  The DME Subcommittee rules provide that the remaining members of the DME Subcommittee shall appoint a new representative of the rehabilitation technology suppliers to fill the remainder of Mr. Elliott’s unexpired term, which will run through June 2015.

The members of the DME Subcommittee solicit suggestions of eligible candidates for their consideration for appointment.  In order to be eligible for appointment, the rehabilitation technology suppliers representative must practice in the particular area for which he or she is appointed, but need not practice exclusively in that area.  The candidate must also be a “Person-in-Charge” of a DME facility within that area of practice.

Suggestions, along with any supporting materials, should be submitted to Cindy Parham, NCBOP Investigations and Inspections Coordinator, on or before April 24, 2014.  Materials may be e-mailed to cparham@ncbop.org, delivered in person to the Board office, or mailed to the Board office with a postmark on or before April 24, 2014.  Anyone wishing to learn more about the duties of a DME Subcommittee member may also contact Ms. Parham with questions.

In May, the DME Subcommittee members will consider any suggestions received by the deadline, as well as any suggestions generated by DME Subcommittee members, and will make an appointment.

 


 

WEDNESDAY, MARCH 19, 2014

Reminder regarding the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule: A Guide for Law Enforcement.

 


 

TUESDAY, MARCH 18, 2014

NOTICE OF PUBLIC HEARING (JULY 14, 2014) ON PROPOSED AMENDMENTS TO RULE 21 NCAC 46 .2507 - ADMINISTRATION OF VACCINES BY PHARMACISTS. Revisions required by changes in pharmacist immunization authority in Session Law 2013-246.

A public hearing will be held on July 14, 2014 at 5:00pm at the NC Board of Pharmacy office, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517.

Any person may object to the proposed amendment by attending the public hearing on July 14, 2014 and/or by submitting a written objection by July 14, 2014 to Jay Campbell, Executive Director, North Carolina Board of Pharmacy, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517, fax (919) 246-1056, e-mail jcampbell@ncbop.org. The North Carolina Board of Pharmacy is interested in all comments pertaining to the proposed rule. All persons interested and potentially affected by the proposal are strongly encouraged to read this entire notice and make comments on the proposed rule.

If an objection is not resolved prior to the adoption of the rule, a person may also submit written objections to the Rules Review Commission. If the Rules Review Commission receives written and signed objections in accordance with G.S. 150B-21.3(b2) from 10 or more persons clearly requesting review by the legislature and the Rules Review Commission approves the rule, the rule will become effective as provided in G.S. 150B-21.3(b1). The Commission will receive written objections until 5:00 p.m. on the day following the day the Commission approves the rule. The Commission will receive those objections by mail, delivery service, hand delivery, or facsimile transmission. If you have any further questions concerning the submission of objections to the Commission, please call a Commission staff attorney at 919-431-3000.

• NOTICE OF TEXT/PUBLIC HEARING:
http://www.ncbop.org/LawsRules/2507NoticeOfTextVaccineAmendmentsMarch2014.pdf

• PROPOSED RULE/AMENDMENT LANGUAGE:
http://www.ncbop.org/LawsRules/2507PropRuleLanguageVaccineAmendmentsMarch2014.pdf

 



NEW CE OPPORTUNITIES: PHARMACISTS & TECHNICIANS, Remember to check our CE page often for upcoming CE programs in your area. (LAST UPDATED APRIL 9, 2014.)


 

FRIDAY, FEBRUARY 21, 2014

NOTICE OF PUBLIC HEARING (JUNE 17, 2014) ON PROPOSED AMENDMENTS TO RULE 21 NCAC 46 .2401 AND .2403 - DISPENSING IN HEALTH DEPARTMENTS. Revisions required by Session Law 2013-23 and the Acting State Health Director's addition of naloxone to the recommended formulary of drugs to be dispensed by registered nurses in local health department clinics.

A public hearing will be held on June 17, 2014 at 9:00am at the NC Board of Pharmacy office, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517.

Any person may object to the proposed amendment by attending the public hearing on June 17, 2014 and/or by submitting a written objection by 9:00am on June 17, 2014 to Jay Campbell, Executive Director, North Carolina Board of Pharmacy, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517, fax (919) 246-1056, e-mail jcampbell@ncbop.org. The North Carolina Board of Pharmacy is interested in all comments pertaining to the proposed rule. All persons interested and potentially affected by the proposal are strongly encouraged to read this entire notice and make comments on the proposed rule.

If an objection is not resolved prior to the adoption of the rule, a person may also submit written objections to the Rules Review Commission. If the Rules Review Commission receives written and signed objections in accordance with G.S. 150B-21.3(b2) from 10 or more persons clearly requesting review by the legislature and the Rules Review Commission approves the rule, the rule will become effective as provided in G.S. 150B-21.3(b1). The Commission will receive written objections until 5:00 p.m. on the day following the day the Commission approves the rule. The Commission will receive those objections by mail, delivery service, hand delivery, or facsimile transmission. If you have any further questions concerning the submission of objections to the Commission, please call a Commission staff attorney at 919-431-3000.

• NOTICE OF TEXT/PUBLIC HEARING:
http://www.ncbop.org/LawsRules/2400ProposedAmendNoticeOfTextFeb2014.pdf


• PROPOSED RULE/AMENDMENT LANGUAGE:
http://www.ncbop.org/LawsRules/2400ProposedAmendRegNursesDispOpioidAntagonistsFeb2014.pdf

 


 

FRIDAY, DECEMBER 6, 2013

FEDERAL DRUG QUALITY AND SECURITY ACT BRINGING CHANGES TO COMPOUNDING PHARMACY REGULATION.  On November 27, 2013, the President signed into law the Drug Quality and Security Act (DQSA).  DQSA focuses on two broad issues:  (1) further refinement of the state and federal roles in regulating compounding pharmacy practices; and (2) creation and implementation of a national “track and trace” program intended to ensure integrity of the prescription drug supply chain.  Compounding pharmacists undoubtedly have questions about the impact of this statute on their practices.  Board staff will continue to provide information as available.  Earlier this week, FDA issued guidance on the new statute.  Compounding pharmacists are strongly advised to read FDA guidance.  It may be found here:

FDA Compounding Q+A: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm339764.htm

FDA Compounding Statement: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/default.htm

 


 

Health Advisories (last updated February 17, 2014) - Check here regularly for the latest alerts and recall notices.

 


 

Medicare/Medicaid (last updated December 2013) - Check here regularly for the latest updates regarding Medicare/Medicaid.


 

Looking for a news item that is no longer here? Try our search page or send an email to Kristin Moore.

 


The North Carolina Board of Pharmacy's mission is to protect the public health, safety and welfare in pharmaceutical matters. The Board sets standards for academic and practical experience programs prior to licensure, issues permits to operate pharmacies and DME facilities, and annually renews licenses, permits and registrations.

For more information, please see About the NCBOP.



Copyright © 2006 North Carolina Board of Pharmacy
site design IV Design